334 related articles for article (PubMed ID: 30029694)
21. Identification of a Novel HADHB Gene Mutation in an Iranian Patient with Mitochondrial Trifunctional Protein Deficiency.
Shahrokhi M; Shafiei M; Galehdari H; Shariati G
Arch Iran Med; 2017 Jan; 20(1):22-27. PubMed ID: 28112527
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts.
Lefort B; Gouache E; Acquaviva C; Tardieu M; Benoist JF; Dumas JF; Servais S; Chevalier S; Vianey-Saban C; Labarthe F
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1292-1299. PubMed ID: 28392417
[TBL] [Abstract][Full Text] [Related]
23. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
[TBL] [Abstract][Full Text] [Related]
24. [Mitochondrial trifunctional protein deficiency: an adult patient with similar progress to Charcot-Marie-Tooth disease].
Yamamoto Y; Matsui N; Hiramatsu Y; Miyazaki Y; Nodera H; Izumi Y; Takashima H; Kaji R
Rinsho Shinkeigaku; 2017 Feb; 57(2):82-87. PubMed ID: 28132977
[TBL] [Abstract][Full Text] [Related]
25. Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency.
Hickmann FH; Cecatto C; Kleemann D; Monteiro WO; Castilho RF; Amaral AU; Wajner M
Biochim Biophys Acta; 2015; 1847(6-7):620-8. PubMed ID: 25868874
[TBL] [Abstract][Full Text] [Related]
26. Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Immonen T; Turanlahti M; Paganus A; Keskinen P; Tyni T; Lapatto R
Acta Paediatr; 2016 May; 105(5):549-54. PubMed ID: 26676313
[TBL] [Abstract][Full Text] [Related]
27. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and progressive retinopathy: one case report followed by ERGs, VEPs, EOG over a 17-year period.
Rigaudière F; Delouvrier E; Le Gargasson JF; Milani P; Ogier de Baulny H; Schiff M
Doc Ophthalmol; 2021 Jun; 142(3):371-380. PubMed ID: 33392894
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.
Boese EA; Jain N; Jia Y; Schlechter CL; Harding CO; Gao SS; Patel RC; Huang D; Weleber RG; Gillingham MB; Pennesi ME
Ophthalmology; 2016 Oct; 123(10):2183-95. PubMed ID: 27491397
[TBL] [Abstract][Full Text] [Related]
29. RETINAL PHENOTYPE IN A CASE OF LCHAD/TFP DEFICIENCY WITH LATE-STAGE DIAGNOSIS.
Knowles JA; Dimopoulos IS; MacDonald IM
Retin Cases Brief Rep; 2019 Summer; 13(3):279-282. PubMed ID: 28301411
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland.
Piekutowska-Abramczuk D; Olsen RK; Wierzba J; Popowska E; Jurkiewicz D; Ciara E; Ołtarzewski M; Gradowska W; Sykut-Cegielska J; Krajewska-Walasek M; Andresen BS; Gregersen N; Pronicka E
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S373-7. PubMed ID: 20814823
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases.
Bo R; Yamada K; Kobayashi H; Jamiyan P; Hasegawa Y; Taketani T; Fukuda S; Hata I; Niida Y; Shigematsu Y; Iijima K; Yamaguchi S
J Hum Genet; 2017 Sep; 62(9):809-814. PubMed ID: 28515471
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
Jones PM; Butt Y; Bennett MJ
Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
34. Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency.
Olpin SE; Clark S; Andresen BS; Bischoff C; Olsen RK; Gregersen N; Chakrapani A; Downing M; Manning NJ; Sharrard M; Bonham JR; Muntoni F; Turnbull DN; Pourfarzam M
J Inherit Metab Dis; 2005; 28(4):533-44. PubMed ID: 15902556
[TBL] [Abstract][Full Text] [Related]
35. Long-chain fatty acid oxidation during early human development.
Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
[TBL] [Abstract][Full Text] [Related]
36. Retinitis pigmentosa as a clinical presentation of LCHAD deficiency: A clinical case and review of the literature.
García García LC; Zamorano Martín F; Rocha de Lossada C; García Lorente M; Luque Aranda G; Escudero Gómez J
Arch Soc Esp Oftalmol (Engl Ed); 2021 Sep; 96(9):496-499. PubMed ID: 34479707
[TBL] [Abstract][Full Text] [Related]
37. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
Gillingham MB; Heitner SB; Martin J; Rose S; Goldstein A; El-Gharbawy AH; Deward S; Lasarev MR; Pollaro J; DeLany JP; Burchill LJ; Goodpaster B; Shoemaker J; Matern D; Harding CO; Vockley J
J Inherit Metab Dis; 2017 Nov; 40(6):831-843. PubMed ID: 28871440
[TBL] [Abstract][Full Text] [Related]
38. Energy exchangers with LCT as a precision method for diet control in LCHADD.
Mozrzymas R; Konikowska K; Regulska-Ilow B
Adv Clin Exp Med; 2017; 26(3):515-525. PubMed ID: 28791828
[TBL] [Abstract][Full Text] [Related]
39. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
